Skip Navigation

European Heart Journal 2002 23(12):926-927; doi:10.1053/euhj.2001.3132
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wollert, K.C.
Right arrow Articles by Drexler, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wollert, K.C.
Right arrow Articles by Drexler, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Chromogranin A in heart failure

K.C. Wollert and H. Drexler

Department of Cardiology and Angiology, Hannover, Germany

References

  1. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962;267:650–654
  2. Braunwald E, Bristow MR. Congestive heart failure. Fifty years of progress. Circulation. 2000;102:14–23[Abstract/Free Full Text]
  3. Ceconi C, Ferrari R, Bachetti T. Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality. Eur Heart J. 2002;23:967–974[Abstract/Free Full Text]
  4. Mouland AJ, Bevan S, White JH, Hendy GN. Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J Biol Chem. 1994;269:6918–6926[Abstract/Free Full Text]
  5. Kim T, Tao-Cheng JH, Eiden LE, Loh YP. Chromogranin A, an ‘on/off’ switch controlling dense-core secretory granule biogenesis. Cell. 2001;106:499–509[CrossRef][ISI][Medline]
  6. Mahata SK, O'Connor DT, Mahata M. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest. 1997;100:1623–1633[ISI][Medline]
  7. Parmer RJ, Mahata M, Gong Y. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J Clin Invest. 2000;106:907–915[ISI][Medline]
  8. Kennedy BP, Mahata SK, O'Connor DT, Ziegler MG. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides. 1998;19:1241–1248[CrossRef][ISI][Medline]
  9. Brekke JF, Kirkeleit J, Lugardon K, Helle KB. Vasostatins. Dilators of bovine resistance arteries. Adv Exp Med Biol. 2000;482:239–246[ISI][Medline]
  10. Ratti S, Curnis F, Longhi R. Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells. J Biol Chem. 2000;275:29257–29263[Abstract/Free Full Text]
  11. Ciesielski-Treska J, Ulrich G, Chasserot-Golaz S. Mechanisms underlying neuronal death induced by chromogranin A-activated microglia. J Biol Chem. 2001;276:13113–13120[Abstract/Free Full Text]
  12. Lugardon K, Raffner R, Goumon Y. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem. 2000;275:10745–10753[Abstract/Free Full Text]
  13. Takiyyuddin MA, Cervenka JH, Sullivan PA. Is physiologic sympathoadrenal catecholamine release exocytotic in humans? Circulation. 1990;81:185–195[Abstract/Free Full Text]
  14. Cryer PE, Wortsman J, Shah SD, Nowak RM, Deftos LJ. Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol. 1991;260:E243–246
  15. O'Connor DT, Bernstein KN. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med. 1984;311:764–770[Abstract]
  16. Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JA, Parmer RJ, O'Connor DT. Chromogranin A. Storage and release in hypertension. Hypertension. 1990;15:237–246[Abstract/Free Full Text]
  17. Mahata SK, Mahata M, Parmer RJ, O'Connor DT. Desensitization of catecholamine release. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344–364) acts at the receptor to prevent nicotinic cholinergic tolerance. J Biol Chem. 1999;274:2920–2928[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wollert, K.C.
Right arrow Articles by Drexler, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wollert, K.C.
Right arrow Articles by Drexler, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?